The Pattern of Dry Eye Disease After Cataract Surgery
Key facts
- Who runs it
- Lithuanian University of Health Sciences
- Where
- Lithuania1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- Mar 2024
- Expected to end
- Sept 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Artificial tears (sodium hyaluronate 0.2%)
- Record updated
- 7 March 2024
Who can take part
- Age
- 50 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Cataract patients from 50 to 90 years old who underwent uncomplicated phacoemulsification performed by one (and same) experienced surgeon
- Patients with no underlying ocular surface diseases (keratitis, keratoconjunctivitis and others)
- Patients who previously did not undergo any ophthalmic surgery
Who cannot take part
- Patients who underwent refractive surgery (LASIK or PRK)
- One or more of the following concomitant medications: psychiatric medicines, antihistamines and/or hormonal replacement
- Severe dry eye disease diagnosed with OSDI/DEQ-5 and at least one of the following tests: TBUT less than 10 seconds, tear osmolarity higher than 308 mOsm/l or positive corneal staining
- Diabetes mellitus
- Systemic connective tissue disease, autoimmune disease
- Neurologic conditions including stroke, Bell's palsy, Parkinson's, trigeminal nerve dysfunction
- Patient expressed his wish to not participate in the study or discontinue it when already enrolled
- Glaucoma
- Contact lens users
- Patients who are already regularly using topical drops or ointments
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Dry eye disease or cataract or ocular surface disease
This trial is currently available in Lithuania.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with ocular surface inflammation, pain biomarkers after cataract surgery according to ocular surface lubrication with artificial tears during long-term follow-up.
The 2 groups in the trial
- Patients who will be using artificial tears before and after cataract surgery
Patients will receive artificial tears 7 days before the cataract surgery and continue to use them for 3 months after the surgery.
Treatment: Artificial tears (sodium hyaluronate 0.2%)
- Patients who will not be using any artificial tears neither before nor after the cataract surgery.
Patients will not receive any artificial tears neither before nor after the cataract surgery.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ocular Surface and Corneal Morphological Changes After the Cataract Surgery and Associations With Inflammatory Biomarkers
- Criteria questions
- Built from NCT06298890, who can take part
- Record updated
- 7 March 2024